-+ 0.00%
-+ 0.00%
-+ 0.00%

Jade Biosciences Expands CFO Brad Dahms' Role to Include Chief Business Officer

PUBT·11/13/2026 12:02:18
Listen to the news
Jade Biosciences Expands CFO Brad Dahms' Role to Include Chief Business Officer
  • Jade Biosciences expanded Chief Financial Officer Brad Dahms' role, adding the title of chief business officer.
  • Dahms will now lead business development and corporate strategy as the pipeline advances toward multiple clinical readouts in 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jade Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611130700PRIMZONEFULLFEED9877006) on November 13, 2026, and is solely responsible for the information contained therein.